World's Best Scientists 2026 revealed!
Daniela Pende

Daniela Pende

D-Index & Metrics

Immunology

D-Index
92
Citations
30813
World Ranking
1006
National Ranking
32

Medicine

D-Index
92
Citations
30813
World Ranking
11315
National Ranking
417

Daniela Pende publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniela Pende sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 221 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniela Pende D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniela Pende sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniela Pende is affiliated with the University of Genoa in Italy and has contributed to research primarily focused on immunology, hematology, and oncology. Their work spans topics such as immune cell function, T-cell and B-cell immunology, and hematopoietic stem cell transplantation, among others.

The scientist has published extensively in the fields of Immunology and Microbiology as well as Medicine. Their subfields of study include Immunology, Hematology, and Oncology. Research areas covered by their publications emphasize:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • IL-33, ST2, and ILC Pathways
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Autoimmune and Inflammatory Disorders Research
  • Immunotherapy and Immune Responses

The recent papers authored or co-authored by Daniela Pende demonstrate contributions to both immunotherapy and transplantation research. Highlights include:

  • "NK cells and ILCs in tumor immunotherapy," 2020, Molecular Aspects of Medicine
  • "Human NK cells, their receptors and function," 2021, European Journal of Immunology
  • "Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer," 2020, Frontiers in Immunology
  • "TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders," 2021, Blood Advances
  • "TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis," 2023, Blood

Daniela Pende's collaboration network includes frequent co-authors such as Lorenzo Moretta, Maria Cristina Mingari, Michela Falco, Raffaella Meazza, and Simona Sivori. The scientist has contributed multiple papers alongside these colleagues, reflecting sustained collaborative research efforts.

Publications by Daniela Pende are commonly found in specialized journals including Frontiers in Immunology, Blood Advances, Blood, HLA, and Molecular Aspects of Medicine. These venues align with their focus on immunological and hematological research domains.

Best Publications

  • Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

    Cristina Bottino;Roberta Castriconi;Daniela Pende;Paola Rivera

  • RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

    Daniela Pende;Silvia Parolini;Anna Pessino;Simona Sivori

  • Major Histocompatibility Complex Class I-related Chain A and UL16-Binding Protein Expression on Tumor Cell Lines of Different Histotypes Analysis of Tumor Susceptibility to NKG2D-dependent Natural Killer Cell Cytotoxicity

    Daniela Pende;Paola Rivera;Stefania Marcenaro;Chien Chung Chang

  • Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

    Loredana Ruggeri;Antonella Mancusi;Marusca Capanni;Elena Urbani

  • NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

    Simona Sivori;Daniela Pende;Cristina Bottino;Emanuela Marcenaro

  • Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

    Régis T. Costello;Simona Sivori;Emanuela Marcenaro;Marina Lafage-Pochitaloff

  • Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

    A Moretta;C Bottino;D Pende;G Tripodi

  • Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

    Alessandro Moretta;Simona Sivori;Massimo Vitale;Daniela Pende

  • The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

    D Pende;R Biassoni;C Cantoni;S Verdiani

  • Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

    Daniela Pende;Stefania Marcenaro;Michela Falco;Stefania Martini

  • Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).

    Daniela Pende;Grazia Maria Spaggiari;Stefania Marcenaro;Stefania Martini

  • NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor

    Massimo Vitale;Mariella Della Chiesa;Simona Carlomagno;Daniela Pende

  • HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

    Alice Bertaina;Pietro Merli;Sergio Rutella;Sergio Rutella;Daria Pagliara

  • Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

    Daniela Pende;Claudia Cantoni;Claudia Cantoni;Paola Rivera;Massimo Vitale

  • HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

    Ennio Carbone;Paola Neri;Maria Mesuraca;Mariateresa T. Fulciniti

  • Human natural killer cell receptors and co‐receptors

    Roberto Biassoni;Claudia Cantoni;Claudia Cantoni;Daniela Pende;Simona Sivori;Simona Sivori

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes

    Alessandro Moretta;Roberto Biassoni;Cristina Bottino;Daniela Pende

Frequent Co-Authors

Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Alessandro Moretta
Alessandro Moretta University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Michela Falco
Michela Falco Istituto Giannina Gaslini
Massimo Vitale
Massimo Vitale University of Genoa
Claudia Cantoni
Claudia Cantoni University of Genoa
Simona Sivori
Simona Sivori University of Genoa
Roberto Biassoni
Roberto Biassoni Istituto Giannina Gaslini
Maurizio Aricò
Maurizio Aricò Azienda USL di Pescara

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, many of which increasingly intersect with nursing and advanced practice roles. For those interested in clinical applications, transitioning to specialized fields such as acute patient care is vital. Programs like acute care nurse practitioner programs offer a pathway for nurse practitioners to deepen their expertise in managing critical conditions, complementing an immunology background.

For students without a nursing foundation, pursuing an online Bachelor of Science in Nursing (BSN) is a practical starting point. Several online BSN programs for non nurses provide flexible and accessible options to enter the nursing field.

Speeding up this educational journey is possible through accelerated BSN programs for non nurses, designed to help career changers or recent graduates fast-track their credentials. Building on the BSN, aspiring practitioners can explore accelerated NP program options to swiftly advance toward becoming nurse practitioners, potentially integrating immunological expertise into patient care.

By combining immunology studies with these nursing pathways, graduates can enhance their career flexibility and contribute meaningfully to both research and frontline healthcare.

Best Scientists Citing Daniela Pende

Trending Scientists

Recently Published Articles